MedPath

Determination of complement binding HLA-C antibodies with single-antigen-expressing cell lines (SAL) in pregnancies complicated by preeclampsia

Completed
Conditions
Pregnancy toxicosis
10026908
Registration Number
NL-OMON38539
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
132
Inclusion Criteria

We select primiparous women with an uncomplicated, term pregnancy (control) and preeclampsia (case) who deliver at the Leiden University Medical Center. Preeclampsia is defined as gestational hypertension (systolic pressure >= 140 mmHg and/or diastolic pressure >= 90 mmHg detected after 20th week of gestation) or worsening of preexistent hypertension and proteinuria (>= 0.3 gr/l/24hours).

Exclusion Criteria

Maternal autoimmune diseases as antiphospholipid syndrome or SLE, drugs, use of immunosuppressive medication, intrauterine infections and bloodtransfusions or organ transplantions in medical history.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath